File Download
Patent History
- ApplicationAU 20030271510 2003-10-08
- PublicationAU 2003271510 2004-05-04
Patent Family
- AU 2003271510 (A1) 2004-05-04
- CN 1723029 (A) 2006-01-18
- EP 1562616 (A2) 2005-08-17
- JP 2006503109 (A) 2006-01-26
- JP 4786341 (B2) 2011-10-05
- US 2004126434 (A1) 2004-07-01
- US 7521071 (B2) 2009-04-21
- US 2008085931 (A1) 2008-04-10
- US 2008089949 (A1) 2008-04-17
- US 2008089951 (A1) 2008-04-17
- US 2008166425 (A1) 2008-07-10
- WO 2004032822 (A2) 2004-04-22
- WO 2008046299 (A1) 2008-04-24
- WO 2008046307 (A1) 2008-04-24
Supplementary
-
Citations:
- Appears in Collections:
published patent: FORMULATION OF ORAL COMPOSITIONS COMPRISING ARSENIC TRIOXIDE AND METHODS OF USE THEREOF
Title | FORMULATION OF ORAL COMPOSITIONS COMPRISING ARSENIC TRIOXIDE AND METHODS OF USE THEREOF |
---|---|
Priority Date | 2003-10-08 PCT/CN2003000843 2002-10-09 US 10/417200P 2003-06-25 US 10/483014P |
Inventors | |
Issue Date | 2004 |
Citation | Australia Published Patent Application AU 2003271510. Australia: IP Australia, 2004 How to Cite? |
Abstract | The present invention provides an oral formulation of arsenic trioxide (As2O3) for the treatment of a variety of hematological malignancies, including acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). The present invention also prides methods for making the oral arsenic tioxide formulation. Methods of using the oral arsenic trioxide formulation are also described. |
Persistent Identifier | http://hdl.handle.net/10722/176542 |
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2012-11-30T08:38:06Z | - |
dc.date.available | 2012-11-30T08:38:06Z | - |
dc.date.issued | 2004 | - |
dc.identifier.citation | Australia Published Patent Application AU 2003271510. Australia: IP Australia, 2004 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/176542 | - |
dc.description.abstract | The present invention provides an oral formulation of arsenic trioxide (As2O3) for the treatment of a variety of hematological malignancies, including acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). The present invention also prides methods for making the oral arsenic tioxide formulation. Methods of using the oral arsenic trioxide formulation are also described. | en_HK |
dc.title | FORMULATION OF ORAL COMPOSITIONS COMPRISING ARSENIC TRIOXIDE AND METHODS OF USE THEREOF | en_HK |
dc.type | Patent | en_US |
dc.description.nature | published_or_final_version | - |
dc.contributor.inventor | Cyrus, Rustam Kumana | en_HK |
dc.contributor.inventor | Kwong, YL | en_HK |
patents.identifier.application | AU 20030271510 | en_HK |
patents.description.assignee | UNIV HONG KONG | en_HK |
patents.description.country | Australia | en_HK |
patents.date.publication | 2004-05-04 | en_HK |
patents.date.application | 2003-10-08 | en_HK |
patents.date.priority | 2003-10-08 PCT/CN2003000843 | en_HK |
patents.date.priority | 2002-10-09 US 10/417200P | en_HK |
patents.date.priority | 2003-06-25 US 10/483014P | en_HK |
patents.description.cc | AU | en_HK |
patents.identifier.publication | AU 2003271510 | en_HK |
patents.relation.family | AU 2003271510 (A1) 2004-05-04 | en_HK |
patents.relation.family | CN 1723029 (A) 2006-01-18 | en_HK |
patents.relation.family | EP 1562616 (A2) 2005-08-17 | en_HK |
patents.relation.family | JP 2006503109 (A) 2006-01-26 | en_HK |
patents.relation.family | JP 4786341 (B2) 2011-10-05 | en_HK |
patents.relation.family | US 2004126434 (A1) 2004-07-01 | en_HK |
patents.relation.family | US 7521071 (B2) 2009-04-21 | en_HK |
patents.relation.family | US 2008085931 (A1) 2008-04-10 | en_HK |
patents.relation.family | US 2008089949 (A1) 2008-04-17 | en_HK |
patents.relation.family | US 2008089951 (A1) 2008-04-17 | en_HK |
patents.relation.family | US 2008166425 (A1) 2008-07-10 | en_HK |
patents.relation.family | WO 2004032822 (A2) 2004-04-22 | en_HK |
patents.relation.family | WO 2008046299 (A1) 2008-04-24 | en_HK |
patents.relation.family | WO 2008046307 (A1) 2008-04-24 | en_HK |
patents.description.kind | A8 | en_HK |
patents.type | Patent_published | en_HK |